Health Professional Radio - Podcast

Dr. Dirk Huebner, MD, Chief Medical Officer at Aptevo Therapeutics , a biotech company, discusses the company's focus on bringing novel immuno-oncology therapeutics to market. They leverage the innovative ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients. #AptevoTherapeutics Dr. Huebner is a Medical Advisor Consul...

Psychiatrist, Dr. Rakesh Amin, MD, discusses the toll that schizophrenia takes on caregivers, how caregivers of schizophrenia patients can best support themselves, as well as their patients, and how caregivers can help patients establish a successful treatment plan. Dr. Amin talks about newer treatment options, such as long-acting injectables, that can help improve patient adherence, reduce stress...

Hema Tallman, SVP and Global Head of BioLife Plasma Services at Takeda, an industry leader in the collection of high-quality plasma and a supporting driver in the production of life-saving plasma-derived therapies (PDTs). She discusses the importance of the consumer experience by leveraging her experience in health retail as she drives BioLife's efforts to create a future-ready organization th...

Dr. David Bearss, PhD, President and CEO at Halia Therapeutics , a clinical-stage biopharma company developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases discusses the company's lead compound, HT-6184, which prevents the formation of the NLRP3 inflammasome complex and subsequently inhibits the production and release of pro-inflammator...

Schizophrenia is a serious and complex mental illness that left untreated can disrupt a person's relationships, physical health, and plans for the future - and it may even lead to repeated cycles of crisis with recurrent episodes. There is hope for people who have schizophrenia to lead a normal life with the right support and treatment. Here to discuss schizophrenia and the importance of manag...

Mark McDonough, CEO of ChromaCode , a molecular diagnostics company, discusses how ChromaCode  technology provides a cost-effective, rapid, and accurate method of testing  clinically actionable biomarkers. He also talks about the partnership with MedGenome to bring affordable diagnostics to India and the middle east. #ChromaCode Mark has over 25 years of experience helping build high growth Health...

Amelia Korangy, Director of External Affairs Strategy and Programs at ViiV Healthcare - the only pharmaceutical company solely focused on HIV, discusses ViiV's investment in HIV prevention for Black women. ViiV’s Risk to Reasons initiative, which includes community grants and resources, recently launched free online activity books to help change the HIV prevention narrative for Black women. Th...

Dr. Steve Marcus, CEO of Cantex Pharmaceutical s, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed discusses 2 clinical trials for azeliragon, an orally active, small molecule, antagonist of the receptor for advanced glycation end products (RAGEs) in various c...

Greg Pierce, SVP and GM of Specialty, Health & Wellness at Synchrony , a financial services company, discusses the over-the-counter (OTC) hearing aids ruling, ways to find and pay an audiologist who can ensure the patient has the right hearing aid for their needs, and how consumers can utilize Synchrony’s network of 260,000 providers (and their 90-year expertise in financing) to ease the path...

The U.S. federal government designated May 11, 2023, as the official end of the COVID-19 health emergency​ in the U.S. But the virus is still active and the leading cause of death in the U.S. among the elderly and immunocompromised, so, it's important to take precautions like getting vaccinated and masking...especially if you have a compromised immune system. Here to talk about the realities o...

Amy Meyer, Manager of Primate Experimentation Campaigns for People for the Ethical Treatment of Animals (PETA) discusses what is happening to animals inside taxpayer-funded laboratories and the public records PETA sued to obtain and why. #PETA Amy Meyer is the manager of primate experimentation campaigns for People for the Ethical Treatment of Animals (PETA). She helps lead the group’s work to shu...

Returning guest, Dr. Douglas Rex, MD, Distinguished Professor Emeritus at Indiana University School of Medicine and a full-time clinical gastroenterologist at Indiana University Hospitals discusses colorectal cancer (CRC), how it is rising in younger adults and underserved communities, and the importance of CRC screenings that are recommended for anyone 45 and older. CRC has a 90% survival rate if...

Dr. Elizabeth Garner, MD, Chief Scientific Officer for Ferring Pharmaceuticals discusses C. difficile infection as a major health threat, its current standard of care, the reason for the recurrence of this contagious, serious, and sometimes life-threatening disease, and a novel FDA-approved treatment that prevents recurrent C. difficile infection in a unique way involving the gut microbiome. #CDif...

Dr. Aaron King, Family Medicine and Diabetes Specialist at MedFirst Primary Care, a Baptist Medical Center affiliate, discusses the recent FDA approval of a label update for Novo Nordisk's RYBELSUS ® (semaglutide) as a first-line option for adults living with type 2 diabetes. He is joined by Beto who is living with type 2 diabetes and shares his experience with being prescribed RYBELSUS ® to m...

Dr. Marija Geertsen, M.D., MBA, Vice President, U.S. Medical Affairs at Lundbeck shares scientific updates about its preventive treatment for migraine in adults, insights from a Harris Poll survey that uncovers racial and ethnic treatment disparities and stigma experienced by people living with migraine, and the company’s commitment to helping people living with brain diseases. For more informatio...

Dr. Mitchell Clionsky, PhD, a board-certified clinical neuropsychologist discusses a book co-authored with Dr. Emily Clionsky, MD, titled " Dementia Prevention : Using Your Head to Save Your Brain." #DementiaPrevention Mitchell Clionsky, PhD is a board-certified clinical neuropsychologist with 45 years of experience evaluating and treating patients with cognitive impairment, dementia, AD...

Dr. Wayne Jenkins, Chief Medical Officer of Centivo,  a new type of health plan for self-funded employers anchored around leading providers of value-based care, discusses the company's mission  to bring affordable, high-quality healthcare to the millions of workers, findings from the company's  2022 healthcare spend analysis and more. #Centivo Dr. Wayne Jenkins is the Chief Medical Officer...

Dr. Colby Kash, a wellness and longevity functional medicine practitioner and a sought-after lecturer on healthcare-related topics​​​,​​ and a co-founder of five biotechnology companies discusses his book "The Autoimmune Plague: How to Regain Sovereignty Over Your Body and Life"​ and the development of the KASH Code, ​an evidence-based blueprint designed to combat the smorgasbord of psyc...

Scott Montgomery, CEO and Director of Advanced Health Intelligence (AHI),  a technology company developing smartphone-based human scanning technology  discusses their name change from Advanced Human Imaging to Advanced Health Intelligence,  the acquisition of Wellteq, a Canadian digital health company, and  the enhanced capabilities of the AHI platform with the integration of Wellteq. www.ahi.tech...

Josh Budman, SVP, Research & Incubation at Net Health , discusses new research that revealed artificial intelligence could save the healthcare industry $360B a year. He talks about what AI is going to mean to the future of healthcare, the challenges facing more widespread adoption, and Net Health’s AI-powered wound care app that is currently being used to improve clinical outcomes, ensure data...

Dr. Darrell Gray, MD, MPH, FACG, Chief Health Equity Officer at Elevance Health discusses how and why health equity should be authentically embedded and reflected across all lines of a company’s business, so that everyone in the healthcare ecosystem benefits, especially patients and their families. #ElevanceHealth Darrell M. Gray, II, MD, MPH, FACG serves as chief health equity officer at Elevance...

Dr. Danielle Zerr , MD, MPH, Medical Director of Infection Prevention at Seattle Children's discusses the expected severe shortage of infectious disease specialists over the next decade, according to projections by the federal Health Resources and Services Administration. She talks about why this shortage matters, some of the challenges in the profession, why she has devoted herself to the inf...

Michael Axt, Chief Member Empowerment Officer at Zelis , a company modernizing the healthcare financial experience, discusses recent research outlining consumer frustration with the healthcare billing process, the lack of processes for correcting errors, and the implications for payers, providers, and consumers. #Zelis Michael Axt is Chief Member Empowerment Officer of Zelis, providing strategic l...

Dr. Paul Lammers, MD, MSc, President and Chief Executive Officer at Triumvira Immunologics discusses the company's work in the development of novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with cancer. #Triumvir Immunologics Paul Lammers, MD, MSc, joined Triumvira Immunologics as President and CEO in January 2018. Befo...

Steve Glover, Co-Founder, Chairman, and CEO of ZyVersa Therapeutics , a clinical-stage specialty biopharmaceutical company discusses the work the company is doing to develop first-in-class drugs for patients with inflammatory or kidney diseases with high unmet medical needs. They are well positioned in the rapidly emerging inflammasome space with a highly differentiated inflammasome inhibitor (IC...